Our treatment plans are customized and built on a foundation of 100+ years of scientific research from allergists across the globe.
We take data seriously. In addition to being highly selective about the lab we partner with, we employ a team of talented and experienced medical and clinical professionals to ensure our tests and process meets the highest standards of quality.
Each Lab that we work with is Clinical Laboratory Improvement Amendments Certified (CLIA) by the Center for Medicare & Medicaid Services (CMS). In order for a lab to be CLIA-certified they must:
- Meet high precision, accuracy, and validity standards
- Obtain both state and federal certifications
- Submit themselves to regular inspections as well as independent third-party performance verifications.
Our test kit uses a method called Dried Blood Spot Testing, a form of collection where patients prick the finger with a micro lancet and then place drops of blood on a card in a designated area. Once dry, the blood spot cards are extremely stable for shipment and storage.
Our blood spot testing method eliminates the need for needles or pricks, and completely eliminates the need to come into the office.
Our third-party labs are the experts in dried blood spot testing technology and we only utilize HIPAA-secure means to share test related data with our team.
Every sample that our lab receives has a unique barcode ID that is used to identify the sample throughout the entire testing process. This barcode ID is linked to the customer and ensures the results are accurately delivered to the correct person and greatly reduces the incidence of associated errors (e.g., a sample mix up because of human error in writing/tracking).
Once your test results are processed, our team will reach out to schedule a virtual consultation with one of our physicians to review your test results with you.
We always encourage sharing your allergy testing results with your healthcare provider. You can print or email a “doctor friendly” version of your results in a format that your physician is used to seeing when normally reviewing lab results.
Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines.Clinical and Experimental Otorhinolaryngology. 2014 Dec; 7(4): 241-249
Safety of sublingual-swallow therapy in children and adults. Intl Arch Allergy Immunol.2000 Mar; 121(3):229-34
Review of 8 studies containing 690 patients. No serious reactions.
Grass pollen specific sublingual/swallow immunotherapy in children: open controlled comparison among different treatment protocols. Allergologia et Immunopathogia 1999. 27(3): 145-51
268 children (age 2-15 years), approximately 96,000 doses of allergy drops
No serious or life-threatening reactions
Adverse events rate: 0.83 per 1000 doses (3% of children in the study)
7 adverse events requiring no treatment (including stomach pain, itchy eyes, nasal congestion)
1 case of hives which required treatment with an antihistamine
There have been a number of studies comparing allergy shots and drops. Some have shown that drops are better at treating nasal allergies, while others have shown that shots are better. Most have shown equal results between the two options. The opinion of Aspire Allergy & Sinus and allergydrops.com is that allergy shots and allergy drops have roughly the same effectiveness at treating allergies, and that allergy drops are safer than shots (though both are very safe if proper precautions are taken).
Here are a few references of studies comparing shots and drops: